Tag: Pharmaceuticals
Biophore ramps up Made-In-India Favipiravir production for Covid-19
Hyderabad-based Biophore India Pharmaceuticals has received the DCGI license to manufacture the API in India and has been cleared for export as well.................
NIPERs must establish national level testing labs for pharma products: Mansukh...
As per Mr Mansukh Mandaviya, Minister of State for Chemicals and Fertilizers, NIPERs can be self-sustainable by generating their own resources through research and testing activities..........................
Navia life Care joins hands with Aptar Pharma to launch MyAdhero...
ADHERO device is India’s first connected device for metered-dose inhalers (MDI).................
IP university to establish endowment in memory of biochemist Y Subbarow
An endowment in the memory and honour of pioneering Indian biochemist Yellapragada SubbaRow, whose 125th birth anniversary is being celebrated this year will be established by the Guru Gobind Singh Indraprastha University..................
BD Medical-Pharmaceutical Systems to hold Technovation Season 9
The event will further Becton Dickinson’s efforts to strengthen partnerships with pharmaceutical companies and bring relevant solutions to create a positive impact on the lives of patients.................
Inspirational Science Programme gets funding boost from Cipla chairman
Generous donation of Rs. 8.7 crore has been committed to the Inspirational Science Programme across India that aims to give Indian teachers new tools for delivering engaging and effective science lessons, and to encourage students to reach.........
Global executive MBA program for pharma industry professionals launched in India
Ahmedabad University in partnership with University of California San Diego has launched two-year masters in business management with pharma specialization programme for working executives, with 27 tailored courses, to begin from Sep 2018.........
Oxytocin formulations banned from 1st July, only KAPL to manufacture the...
While Oxytocin formulations ban would come into effect from 1st July 2018, only the public sector unit, Karnataka Antibiotics & Pharmaceuticals Ltd (KAPL) has been allowed to manufacture the drug for domestic use only............
“We believe genomics should be available to everybody”
In an exclusive interaction with the BioVoice, Dr Axel Schumacher, CEO and co-founder of blockchain-enabled genomic data-hub startup Shivom, shared insights on his company's operations and India plans. Dr Schumacher who has over 20 years’ experience in the field of genetics, is highly excited on the future of genetics globally. Read on:
AIMED terms latest MedTech preferential market access policy as disappointing
The Association of Indian Medical Device Industry has said that by denying preferential pricing to Indian manufacturers, the draft policy guidelines can be said to be bordering on encouraging, what it called, pseudo manufacturing.............